MENU
+Compare
BAX
Stock ticker: NYSE
AS OF
Nov 19, 04:59 PM (EDT)
Price
$17.69
Change
-$0.46 (-2.53%)
Capitalization
9.33B

BAX Baxter International Forecast, Technical & Fundamental Analysis

Baxter offers a variety of medical supplies and equipment to providers... Show more

BAX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BAX with price predictions
Nov 18, 2025

BAX sees its Stochastic Oscillator ascending out of oversold territory

On November 13, 2025, the Stochastic Oscillator for BAX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 61 instances where the indicator left the oversold zone. In of the 61 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BAX's RSI Oscillator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 18, 2025. You may want to consider a long position or call options on BAX as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BAX just turned positive on November 18, 2025. Looking at past instances where BAX's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BAX advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

BAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BAX entered a downward trend on November 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BAX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.288) is normal, around the industry mean (9.047). P/E Ratio (87.846) is within average values for comparable stocks, (152.239). BAX's Projected Growth (PEG Ratio) (33.637) is very high in comparison to the industry average of (2.537). BAX has a moderately high Dividend Yield (0.038) as compared to the industry average of (0.017). P/S Ratio (0.845) is also within normal values, averaging (111.346).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
BAX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BAX is expected to report earnings to fall 20.83% to 54 cents per share on February 12

Baxter International BAX Stock Earnings Reports
Q4'25
Est.
$0.55
Q3'25
Beat
by $0.09
Q2'25
Missed
by $0.02
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.06
The last earnings report on October 30 showed earnings per share of 68 cents, beating the estimate of 60 cents. With 2.67M shares outstanding, the current market capitalization sits at 9.33B.
A.I.Advisor
published Dividends

BAX paid dividends on October 01, 2025

Baxter International BAX Stock Dividends
А dividend of $0.17 per share was paid with a record date of October 01, 2025, and an ex-dividend date of August 29, 2025. Read more...
A.I. Advisor
published General Information

General Information

a provider of a portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Baxter Parkway
Phone
+1 224 948-2000
Employees
60000
Web
https://www.baxter.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IONL45.002.16
+5.04%
GraniteShares 2x Long IONQ Daily ETF
XSLV45.300.32
+0.72%
Invesco S&P SmallCap Low Volatility ETF
SRHR53.680.31
+0.58%
SRH REIT Covered Call ETF
BFRE28.98N/A
N/A
Westwood LBRTY Global Equity ETF
CRF7.77-0.02
-0.26%
Cornerstone Total Return Fund

BAX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been closely correlated with ALGN. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+2.14%
ALGN - BAX
72%
Closely correlated
-0.26%
LUNG - BAX
53%
Loosely correlated
+3.31%
STE - BAX
51%
Loosely correlated
+0.24%
SYK - BAX
51%
Loosely correlated
-0.17%
XRAY - BAX
47%
Loosely correlated
-1.25%
More

Groups containing BAX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+2.14%
BAX
(2 stocks)
71%
Closely correlated
-0.74%
Pharmaceuticals
(378 stocks)
47%
Loosely correlated
-0.45%
Pharmaceuticals: Other
(103 stocks)
42%
Loosely correlated
-0.22%